NIBAN1 and benign prostatic hyperplasia: Furthermore, differential quantitative proteomic analysis of patients with PCa and benign prostatic hyperplasia (BPH) showed a significant decrease in FKBP5, FAM129A, RAB27A, FASN, NEFH proteins after local PCa treatment.